|
Sign In to gain access to subscriptions and/or personal tools.
|
92K-GL (MMP-9) and 72K-GL (MMP-2) are Produced in vivo by Human Oral Squamous Cell Carcinomas and can Enhance FIB-CL (MMP-1) Activity in vitro
K.L. Pickett
Department of Orthodontics, University of Alabama at Birmingham
G.J. Harber
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Oral Cancer Research Center, University of Alabama at Birmingham
A.A. DeCarlo
Department of Microbiology, University of Alabama at Birmingham, Department of Periodontics, University of Alabama at Birmingham
P. Louis
Department of Oral Maxillofacial Surgery, University of Alabama at Birmingham
S. Shaneyfelt
Oral Cancer Research Center, University of Alabama at Birmingham, Department of Restorative Dentistry, University of Alabama at Birmingham
L.J. Windsor
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Oral Cancer Research Center, University of Alabama at Birmingham
M.K. Bodden
Oral Cancer Research Center, University of Alabama at Birmingham, Department of Restorative Dentistry, University of Alabama at Birmingham
Previous studies have shown a correlation between the production of certain matrix metalloproteinases (MMPs), especially the gelatinases, by malignant tumors and the progression of these cancers as they invade and metastasize through the extracellular matrix and basement membranes. However, very few of these studies examined this relationship in human oral cancer in vivo, and none addressed the issue of how combinations of the MMPs may further enhance tumor progression. To determine which MMPs are produced in vivo by human oral cancers, we used specific anti-human-MMP antibodies and immunocytochemistry (ICC) methods to examine oral cancer tissue specimens from 20 surgery patients. The ICC data indicated that 72-kDa (72K-GL) and 92-kDa gelatinases (92K-GL) were produced in vivo by discreet clusters of tumor cells and by stromal fibroblasts, vascular endothelial cells (72K-GL), and PMNs (92K-GL). Some stromal fibroblasts near the tumors also appeared to produce fibroblast-type collagenase (FIB-CL), a finding confirmed by Western blot analysis of media conditioned by oral tumor explant cultures. ICC results indicated that 5 of the 20 tumors coincidentally produced all three MMPs. To examine how the two gelatinases and FIB-CL may interact in vitro to degrade fibrillar type I collagen, a major structural component of the extracellular matrix, we used a modified FIB-CL activity assay. Combinations of the gelatinases and FIB-CL were incubated with a 3H-collagen substrate, with the results compared with the combination of stromelysin-1 (SL-1, a superactivator of FIB-CL) and FIB-CL. 92K-GL caused a nine-fold increase in collagenase activity, equivalent to SL-1, while 72K-GL produced a four-fold increase. These results indicate that human oral cancers produce 92K-GL, 72K-GL, and FIB-CL in vivo and that the gelatinases and FIB-CL cooperate to enhance collagen degradation greatly in vitro.
Key Words: oral cancer • gelatinases A and B • collagenase activity • immunocytochemistry
REFERENCES
- Aimes RT, Quigley JP (1995). Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4 and 1/4-length fragments. J Biol Chem 270:5872-5876.[Abstract/Free Full Text]
- Ballin M., Gomez DE, Sinha CC, Thorgeirsson UP (1988). Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154:832-838.[CrossRef][Medline]
[Order article via Infotrieve]
- Bernhard EJ, Muschel RJ, Hughes EN (1990). Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872-3877.
- Birkedal-Hansen H. (1987). Catabolism and turnover of collagens: collagenases. Meth Enzymol 144:140-171.[Medline]
[Order article via Infotrieve]
- Birkedal-Hansen H., Birkedal-Hansen B., Windsor LJ, Lin HY, Taylor RE, Moore WG (1989). Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis. Immunol Invest 18:211-224.[Medline]
[Order article via Infotrieve]
- Birkedal-Hansen H., Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B., DeCarlo A., et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.[Abstract/Free Full Text]
- Cotran RS, Kumar V., Robbins SL (1989). Cellular injury and adaption. Inflammation and repair. In: Pathologic basis of disease. Cotran RS, Kumar V, Robbins SL, editors. Philadelphia: W.B. Saunders Company, pp. 1-87.
- Crabbe T., O'Connell JP, Smith BJ, Docherty AJ (1994). Reciprocated matrix metelloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry 33:14419-14425.
- Freije JM, Diez-Itza I., Balbin M., Sanchez LM, Blasco R., Tolivia J., et al. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773.[Abstract/Free Full Text]
- Fridman R., Toth M., Pena D., Mobashery S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555.[Abstract/Free Full Text]
- Fullmer HM, Gibson WA, Lazarus GS, Bladen HA, Whedon KA (1969). The origin of collagenase in periodontal tissues of man. J Dent Res 48:646-651.
- Gross J., Lapiere CM (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48:147-155.
- Henson DE (1996). Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst 88:1015-1016.[Free Full Text]
- Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ (1996). Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054-1059.[Abstract/Free Full Text]
- Kubota S., Mitsudomi T.,Yamada Y. (1991). Invasive human fibrosarcoma DNA mediated induction of a 92 kDa gelatinase/type IV collagenase leads to an invasive phenotype. Biochem Biophys Res Commun 181:1539-1547.[CrossRef][Medline]
[Order article via Infotrieve]
- Kusukawa J., Sasaguri Y., Shima I., Kameyama T., Morimatsu M. (1993). Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 99:18-23.[Medline]
[Order article via Infotrieve]
- Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336.[CrossRef][Medline]
[Order article via Infotrieve]
- Lyons JG, Birkedal-Hansen B., Moore WG, O'Grady RL, Birkedal-Hansen H. (1991). Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochem 30:1449-1456.[CrossRef][Medline]
[Order article via Infotrieve]
- Monteagudo C., Merino MJ, San-Juan J., Liotta LA, Stetler-Stevenson WG (1990). Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592.[Abstract]
- Murphy G., Cocket MI, Stephens PE, Smith BJ, Docherty Ajp (1987). Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248:265-268.[Medline]
[Order article via Infotrieve]
- Murphy G., Willenbrock F., Crabbe T., O'Shea M., Ward R., Atkinson S., et al. (1995). Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 23:31-35.
- Poulsom R., Pignatelli M., Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, et al. (1992). Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396.[Abstract]
- Sang QA, Douglas DA (1996). Computational sequence analysis of matrix metalloproteinases. J Prot Chem 15:137-160.[CrossRef][Medline]
[Order article via Infotrieve]
- Sang QA, Bodden MK, Windsor LJ (1996). Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J Prot Chem 15:243-253.[Medline]
[Order article via Infotrieve]
- Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., et al. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.[CrossRef][Medline]
[Order article via Infotrieve]
- Simmer JP, Fukae M., Tanabe T., Yamakoshi Y., Uchida T., Xue J., et al. (1998). Purification, characterization, and cloning of enamel matrix serine proteinase 1. J Dent Res 77:377-386.
- Stearns ME, Wang M. ( 1993). Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53:878-883.[Abstract/Free Full Text]
- Stetler-Stevenson WG (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metas Rev 9:289-303.[CrossRef][Medline]
[Order article via Infotrieve]
- Stetler-Stevenson WG, Ray JM (1994). Genetic modulation of TIMP-2 in human melanoma cells: modulation of the invasive phenotype. Ann NY Acad Sci 732:233-247.[Medline]
[Order article via Infotrieve]
- Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441.[Abstract]
- Strongin AY, Collier I., Bannikov G., Marmer BL, Grant GA, Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem 270:5331-5338.[Abstract/Free Full Text]
- Windsor LJ, Grenett H., Birkedal-Hansen B., Bodden MK, Engler JA, Birkedal-Hansen H. (1993). Cell type-specific regulation of SL-1 and SL-2 genes, induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 268:17341-17347.[Abstract/Free Full Text]
- Windsor LJ, Steele DL, Leblanc SB, Taylor KB (1997). Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin. Biochim Biophys Acta 1334:261-272.[Medline]
[Order article via Infotrieve]
Journal of Dental Research, Vol. 78, No. 7,
1354-1361 (1999)
DOI: 10.1177/00220345990780071001
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. D. Andl, T. Mizushima, H. Nakagawa, K. Oyama, H. Harada, K. Chruma, M. Herlyn, and A. K. Rustgi
Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo
J. Biol. Chem.,
January 10, 2003;
278(3):
1824 - 1830.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lu, H.-H. Chua, S.-Y. Chen, J.-Y. Chen, and C.-H. Tsai
Regulation of Matrix Metalloproteinase-1 by Epstein-Barr Virus Proteins
Cancer Res.,
January 1, 2003;
63(1):
256 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Behzadian, X.-L. Wang, L. J. Windsor, N. Ghaly, and R. B. Caldwell
TGF-{beta} Increases Retinal Endothelial Cell Permeability by Increasing MMP-9: Possible Role of Glial Cells in Endothelial Barrier Function
Invest. Ophthalmol. Vis. Sci.,
March 1, 2001;
42(3):
853 - 859.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. E. Brinckerhoff, J. L. Rutter, and U. Benbow
Interstitial Collagenases as Markers of Tumor Progression
Clin. Cancer Res.,
December 1, 2000;
6(12):
4823 - 4830.
[Abstract]
[Full Text]
|
|
|
|
|
